支气管扩展剂在儿童急诊室的支气管炎使用中的异质性:一个多中心的PEDSnet研究
Andrea Rivera-Sepulveda1, Timothy Maul2, Cara Reedy3
1Department of Pediatrics, Division of Emergency Medicine and Urgent Care, Nemours Children's Health, Orlando, FL.
The Journal of emergency medicine
|October 25, 2025
概括
婴儿支气管炎的支气管扩展剂的使用在儿科急诊室有很大差异,受患者和地点因素的影响. 目前的预测模型显示高精度但低灵敏度识别患者不太可能接受治疗.
科学领域:
- 儿科急救医学 儿科急救医学
- 呼吸系统疾病研究 呼吸系统疾病研究
- 临床实践指南 临床实践指南
背景情况:
- 尽管2014年的指导方针建议不使用常规支气管扩展剂治疗支气管炎,但在儿科急诊室仍然存在显著的实践差异.
- 这种变化凸显了基于证据的建议和临床实施之间的差距.
研究的目的:
- 调查与小儿支气管炎病例中支气管扩展剂的使用相关的人口,临床和机构因素.
- 开发一种预测模型,用于识别支气管扩展剂使用的关键相关物.
主要方法:
- 一项多中心的回顾性研究分析了2019年9个PEDSnet机构3-24个月龄14213名患有支气管炎的儿童的数据.
- 排除标准包括早产,并发症和先前的反应性气道疾病. 采用随机森林模型来确定支气管扩展剂的预测因素.
主要成果:
- 支气管扩展剂在29%的病例中被使用,根据地理位置,患者年龄,同时使用类固醇,呼吸速率和先前的诊断观察到显著的变化.
- 该预测模型实现了85%的准确性,25%的灵敏度和98%的特异性,其中类固醇使用,地理位置和年龄被确定为关键相关因素.
结论:
- 支气管扩展剂用于支气管炎的使用是高度可变的,并与多个患者和特定地点的因素相关.
- 虽然开发的模型可以识别不太可能接受支气管扩展剂的患者,但其低灵敏度限制了实际临床应用.
- 建议对表型驱动的支气管炎护理进行进一步的研究,谨慎避免从观察到的关联中假定治疗益处.
相关概念视频
Inhaled Medications
735
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
735
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K


